In 2000, neurosurgeon Kevin Tracey and colleagues at the Feinstein Institutes for Medical Research published a landmark finding in Nature: electrically stimulating the vagus nerve in rodents dramatically reduced the production of tumour necrosis factor (TNF) during endotoxaemia, preventing lethal septic shock. This discovery — that a nerve could directly control the immune system’s inflammatory response — launched the field now known as bioelectronic medicine and revealed the cholinergic anti-inflammatory pathway, arguably the most important immunological function of the vagus nerve.
The Inflammatory Reflex
The cholinergic anti-inflammatory pathway is the efferent (outgoing) arm of what Tracey termed the “inflammatory reflex” — a complete neural circuit through which the nervous system detects and regulates inflammation in real time. The afferent (incoming) arm works like this: when peripheral tissues are injured or infected, immune cells release pro-inflammatory cytokines (TNF-alpha, interleukin-1 beta, IL-6, HMGB1). Vagal afferent fibres detect these inflammatory signals, primarily through receptors in the gut, liver, and other visceral organs. These signals travel up the vagus to the nucleus tractus solitarius (NTS) in the brainstem, informing the brain that inflammation is occurring.
The brain then activates the efferent arm — the cholinergic anti-inflammatory pathway proper. Efferent vagal signals travel down to the coeliac ganglion, where they synapse onto the splenic nerve. The splenic nerve releases noradrenaline in the spleen, which activates a specific subset of T cells (ChAT-positive T cells) that produce acetylcholine. This acetylcholine binds to alpha-7 nicotinic acetylcholine receptors (alpha-7 nAChR) on splenic macrophages. The downstream effect: suppression of NF-kappa-B signalling, the master transcription factor for inflammatory gene expression. The result is a rapid, targeted reduction in TNF-alpha, IL-1 beta, IL-6, and HMGB1 production.
Why This Pathway Matters
The inflammatory reflex provides something no drug can perfectly replicate: real-time, reflexive regulation of inflammation. Just as the baroreflex adjusts blood pressure moment to moment, the inflammatory reflex continuously calibrates the immune response — enough inflammation to fight infection, not so much that it damages host tissue. Chronic inflammation — when this calibration fails — underlies a vast range of diseases: rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, type 2 diabetes, neurodegeneration, and even depression. The discovery that the vagus nerve is a key regulator of this balance reframed inflammation as a neurologically modifiable process.
This also explained a longstanding clinical observation: why people with higher vagal tone (measured by HRV) tend to have lower levels of circulating inflammatory markers. The Wang et al. 2026 review in Frontiers in Cardiovascular Medicine confirmed that low HRV — specifically RMSSD below 15 ms — is associated with elevated systemic inflammation and a 32–45 percent higher risk of first cardiovascular events. The cholinergic anti-inflammatory pathway provides the mechanistic bridge between vagal tone and inflammatory status.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Bioelectronic Medicine: VNS for Autoimmune Disease
Tracey’s discovery catalysed a new therapeutic approach: using electrical stimulation of the vagus nerve to treat inflammatory diseases directly. SetPoint Medical, co-founded by Tracey, developed a miniaturised implantable vagus nerve stimulator specifically designed to activate the cholinergic anti-inflammatory pathway. Their pilot studies in rheumatoid arthritis patients showed significant reductions in TNF production and meaningful improvements in DAS28 disease activity scores — in patients who had failed multiple conventional disease-modifying drugs. The device received FDA Breakthrough Device designation for rheumatoid arthritis.
The rheumatoid arthritis application is particularly compelling because the disease is driven by excessive TNF-alpha production — the exact cytokine the cholinergic anti-inflammatory pathway most potently suppresses. Rather than systemically blocking TNF with biological drugs (which carry risks of infection and malignancy), VNS activates the body’s own neural anti-inflammatory circuit. Early data suggested that brief daily stimulation sessions (one to four minutes) could produce sustained reductions in joint inflammation and systemic inflammatory markers.
Beyond Rheumatoid Arthritis
The cholinergic anti-inflammatory pathway is not disease-specific — it regulates fundamental inflammatory signalling. Research is exploring VNS-based approaches for several inflammatory conditions. In Crohn’s disease, a pilot study showed that chronic cervical VNS could induce clinical remission in patients with moderate disease, with corresponding reductions in faecal calprotectin (a biomarker of intestinal inflammation). Postoperative ileus — the gut paralysis that follows abdominal surgery — involves inflammation-driven impairment of enteric neural circuits, and perioperative VNS is being investigated to prevent it. Preclinical data in sepsis models continues to show that vagal activation reduces mortality from uncontrolled systemic inflammation.
Kidney ischaemia-reperfusion injury, stroke-related neuroinflammation, and metabolic syndrome are all under active investigation. The common thread is that excessive or dysregulated inflammation drives tissue damage, and the cholinergic anti-inflammatory pathway represents a targeted neural mechanism to suppress it.
The Alpha-7 Receptor: The Molecular Target
The alpha-7 nicotinic acetylcholine receptor (alpha-7 nAChR) is the critical molecular gatekeeper of the pathway. It is expressed on macrophages, dendritic cells, and other immune cells. When acetylcholine (or nicotine, which is an alpha-7 agonist) binds this receptor, it triggers intracellular signalling cascades that suppress NF-kappa-B activation, reduce HMGB1 release, and shift macrophage polarisation from the pro-inflammatory M1 phenotype toward the anti-inflammatory M2 phenotype. This receptor is why smoking — despite its many harms — has a paradoxically protective effect against ulcerative colitis: nicotine activates alpha-7 nAChR on gut immune cells. Pharmaceutical companies are developing selective alpha-7 agonists as anti-inflammatory drugs, though achieving the targeted, reflexive regulation that neural stimulation provides has proved challenging with systemic drugs.
Can You Activate This Pathway Without a Device?
The question most people ask: can lifestyle interventions activate the cholinergic anti-inflammatory pathway? The evidence is indirect but consistent. Activities that demonstrably increase vagal tone — slow diaphragmatic breathing (particularly at approximately six breaths per minute, as shown in the Bernardi et al. 2001 BMJ study on rosary prayer and mantra recitation), meditation (the 2021 meta-analysis in Psychosomatic Medicine confirmed that mindfulness significantly increases RMSSD), regular aerobic exercise, and cold-water face immersion (the Ackermann 2022 Psychophysiology meta-analysis on the diving reflex) — would be expected to enhance cholinergic anti-inflammatory pathway activity through increased vagal output.
However, there is an important distinction between modestly increasing baseline vagal tone through lifestyle practices and the targeted electrical activation used in clinical studies. The VNS devices used in Tracey’s research deliver specific stimulation parameters (frequency, pulse width, current) designed to maximally activate the efferent inflammatory reflex. Whether breathing exercises produce sufficient vagal efferent activation to meaningfully suppress cytokine production in someone with active autoimmune disease remains unproven. Lifestyle vagal enhancement is best understood as health-promoting maintenance rather than a substitute for medical treatment of inflammatory disease.
Fascinated by how your vagus nerve regulates immunity and inflammation? Get the Vagus Nerve & Me eBook for the complete science of vagal function — from inflammatory reflexes to practical methods for enhancing vagal tone.
